CN1242373A - 阿拉伯糖腺嘌呤衍生物 - Google Patents
阿拉伯糖腺嘌呤衍生物 Download PDFInfo
- Publication number
- CN1242373A CN1242373A CN99108908A CN99108908A CN1242373A CN 1242373 A CN1242373 A CN 1242373A CN 99108908 A CN99108908 A CN 99108908A CN 99108908 A CN99108908 A CN 99108908A CN 1242373 A CN1242373 A CN 1242373A
- Authority
- CN
- China
- Prior art keywords
- compound
- ara
- derivatives
- virus
- ada
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17720998A JP3619017B2 (ja) | 1998-06-24 | 1998-06-24 | 新規アラビノシルアデニン誘導体 |
JP177209/1998 | 1998-06-24 | ||
JP177209/98 | 1998-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1242373A true CN1242373A (zh) | 2000-01-26 |
CN1146573C CN1146573C (zh) | 2004-04-21 |
Family
ID=16027087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB991089081A Expired - Fee Related CN1146573C (zh) | 1998-06-24 | 1999-06-24 | 阿拉伯糖腺嘌呤衍生物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6242429B1 (zh) |
EP (1) | EP0967220B1 (zh) |
JP (1) | JP3619017B2 (zh) |
KR (1) | KR100624050B1 (zh) |
CN (1) | CN1146573C (zh) |
AT (1) | ATE236923T1 (zh) |
DE (1) | DE69906625T2 (zh) |
ES (1) | ES2196676T3 (zh) |
TW (1) | TW564249B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ513096A (en) * | 1999-02-01 | 2003-01-31 | Univ Virginia | Compositions for treating inflammatory response |
CN1370170A (zh) * | 1999-05-25 | 2002-09-18 | 宾夕法尼亚州研究基金会 | Dna甲基转移酶抑制剂 |
EP1420021A1 (en) * | 1999-05-25 | 2004-05-19 | The Penn State Research Foundation | DNA Methyltransferase inhibitors |
CN1325504C (zh) | 2002-01-10 | 2007-07-11 | 宾夕法尼亚州研究基金会 | 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法 |
JP2006502974A (ja) | 2002-05-17 | 2006-01-26 | ニューロジェン コーポレイション | 置換環縮合イミダゾール誘導体:gabaa受容体リガンド |
KR20040036417A (ko) * | 2002-10-25 | 2004-04-30 | 정낙신 | 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물 |
JP2008516938A (ja) * | 2004-10-15 | 2008-05-22 | アストラゼネカ アクチボラグ | 置換アデニンとその使用 |
JP5070550B2 (ja) * | 2006-04-13 | 2012-11-14 | 国立大学法人北海道大学 | 抗ヘルペスウイルス活性を有するヌクレオシド誘導体 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5545625A (en) | 1978-09-26 | 1980-03-31 | Ajinomoto Co Inc | 2-methyl-n6-substituted adenine-arabinoside and its preparation |
JPS55160797A (en) * | 1979-05-31 | 1980-12-13 | Ajinomoto Co Inc | Purine nucleoside derivative |
AU575438B2 (en) | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
JPS6299395A (ja) | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | 2−アルキニルアデノシンおよび抗高血圧剤 |
AU8276187A (en) | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
JPH0723394B2 (ja) | 1986-11-27 | 1995-03-15 | 日本臓器製薬株式会社 | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
DE3739366A1 (de) * | 1987-04-10 | 1988-10-27 | Boehringer Mannheim Gmbh | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel |
GB8712745D0 (en) | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
GB2226027B (en) | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
JPH0725785B2 (ja) | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
DK0550631T3 (da) | 1990-09-25 | 1997-01-20 | Rhone Poulenc Rorer Int | Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi |
HUT61567A (en) | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
EP0601322A3 (en) * | 1992-10-27 | 1994-10-12 | Nippon Zoki Pharmaceutical Co | Adenosine deaminase inhibitor. |
-
1998
- 1998-06-24 JP JP17720998A patent/JP3619017B2/ja not_active Expired - Fee Related
-
1999
- 1999-06-22 KR KR1019990023448A patent/KR100624050B1/ko not_active IP Right Cessation
- 1999-06-23 ES ES99111945T patent/ES2196676T3/es not_active Expired - Lifetime
- 1999-06-23 TW TW088110523A patent/TW564249B/zh not_active IP Right Cessation
- 1999-06-23 AT AT99111945T patent/ATE236923T1/de not_active IP Right Cessation
- 1999-06-23 EP EP99111945A patent/EP0967220B1/en not_active Expired - Lifetime
- 1999-06-23 DE DE69906625T patent/DE69906625T2/de not_active Expired - Fee Related
- 1999-06-24 CN CNB991089081A patent/CN1146573C/zh not_active Expired - Fee Related
- 1999-06-24 US US09/339,257 patent/US6242429B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69906625T2 (de) | 2004-02-05 |
DE69906625D1 (de) | 2003-05-15 |
TW564249B (en) | 2003-12-01 |
EP0967220B1 (en) | 2003-04-09 |
CN1146573C (zh) | 2004-04-21 |
KR100624050B1 (ko) | 2006-09-19 |
ES2196676T3 (es) | 2003-12-16 |
EP0967220A1 (en) | 1999-12-29 |
JP2000007695A (ja) | 2000-01-11 |
JP3619017B2 (ja) | 2005-02-09 |
US6242429B1 (en) | 2001-06-05 |
KR20000006339A (ko) | 2000-01-25 |
ATE236923T1 (de) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5547941A (en) | Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions | |
US5032583A (en) | 2,N-6-disubstituted adenosines and their antihypertensive methods of use | |
CA2001715C (en) | Carbocyclic nucleosides and nucleotides | |
JPH08501071A (ja) | 1,5−アンヒドロヘキシトールヌクレオシド類似体および該類似体の医薬としての使用 | |
KR970005326B1 (ko) | 신규 항바이러스제 | |
JPH07500317A (ja) | 1,3−オキサチオランヌクレオシド類似体 | |
JPS61280500A (ja) | ヌクレオシド化合物 | |
EP0632048A1 (en) | Phosphonate-nucleotide ester derivatives | |
HU210803A9 (en) | 1,3-oxathiolane nucleoside analogues | |
KR20010031875A (ko) | 화학 화합물 | |
JP2873086B2 (ja) | 複素環化合物 | |
JP2003532735A (ja) | 抗ウイルスピリミジンヌクレオシド類 | |
CN1242373A (zh) | 阿拉伯糖腺嘌呤衍生物 | |
FI91156C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
EP1706405B1 (en) | 4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity | |
CN1159183A (zh) | 作为抗癌和抗病毒剂的二-(2-卤代乙基)氨基苯基取代的偏端霉素衍生物 | |
AU5691094A (en) | Dihydropyrimidine nucleosides with antiviral properties | |
HU210425B (en) | Process for producing a new ester derivative of acyclovir and pharmaceutical compositions containing that | |
US4594350A (en) | (3-ethoxypropionate) esters of cyclaradine | |
JPH07502741A (ja) | 治療用ヌクレオシド | |
US5283331A (en) | 2-halogeno-oxetanocin A and phosphoric ester thereof | |
EP0097039A1 (en) | 5-(E-2-halovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in treating viral infections | |
US5126347A (en) | Isomeric dideoxynuclesides | |
JP3068175B2 (ja) | イソチアゾロ〔5,4―b〕ピリジン誘導体 | |
CN118005694A (zh) | 一种环状核苷类似物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CI01 | Publication of corrected invention patent application |
Correction item: Denomination of Invention Correct: Arabia sugar adenine derivatives False: Arabia adenine adenine derivatives Number: 4 Volume: 16 |
|
CI02 | Correction of invention patent application |
Correction item: Denomination of Invention Correct: Arabia sugar adenine derivatives False: Arabia adenine adenine derivatives Number: 4 Page: The title page Volume: 16 |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |